Register
Register with JOC.com and receive 5 free pieces of content for the first thirty days. After thirty days, you will receive 3 pieces of content and after sixty days you will receive 1 piece of content. To receive full access,
Subscribe Today. You can also subscribe to our daily newsletter.
Exclusive content, features, opinions and comment - hand-picked by our editors, just for you.
Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
Track the industry of your choice with a daily newsletter specific to that industry.
Stay on top of your investments. Track stock prices in your portfolio.
NOTE :
The monthly duration product is an auto renewal based product. Once subscribed, subject to your card issuer s permission we will charge your card/ payment instrument each month automatically and renew your subscription.
In the Annual duration product we offer both an auto renewal based product and a non auto renewal based product.
Bharat Biotech vaccine may cost less than Serum s; govt working on pricing Ahead of the massive inoculation drive starting next week, the government is engaged with the vaccine makers to discuss their final pricing, according to people in the know. They indicated that Hyderabad-based player Bharat Biotech could price its indigenous candidate Covaxin lower than Covishield the AstraZeneca-Oxford vaccine manufactured by Serum Institute of India. The final contract is expected to be signed soon. Pricing took time as the government tried to get the best deal possible for the initial roll out.
Govt to hold spectrum auctions from March 1; DoT invites applications